Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study

Post time 2024-4-29 14:42:54

journal：Clinical Genitourinary Cancer

Authors：Chisato Narita; Fumihiko Urabe; Wataru Fukuokaya; Kosuke Iwatani; Yu Imai; Keiji Yasue; Keiichiro Mori; Koichi Aikawa; Takafumi Yanagisawa; Shoji Kimura; Kojiro Tashiro; Shunsuke Tsuzuki; Yuta Yamada; Steffi Kar Kei Yuen; Jeremy Yuen-Chun Teoh; Tatsuya Shimomura; Hiroki Yamada; Akira Furuta; Jun Miki; Takahiro Kimura

Published date：2024-3-

DOI：10.1016/j.clgc.2024.102082

PDF link：https://www.sciencedirect.com/sc ... 558767324000533/pdf

Article link：http://dx.doi.org/10.1016/j.clgc.2024.102082

Article Source：Elsevier BV。

Remark：

Post time 2024-4-29 14:42:55

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study